Vaginal Atrophy Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Vaginal Atrophy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

Breast CancerVaginal DrynessVulvovaginal Atrophy
Centre Oscar Lambret75 enrolled1 locationNCT06900374
Recruiting
Phase 4

Postpartum Vaginal Estrogen for Breastfeeding Patients

BreastfeedingVaginal AtrophyPostpartum Sexual Dysfunction
University Hospitals Cleveland Medical Center100 enrolled1 locationNCT05457972
Recruiting
Phase 4

ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

Vaginal Atrophy
Stratpharma AG10 enrolled1 locationNCT07346287
Recruiting
Phase 4

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Breast CancerVulvovaginal Atrophy
University Hospital, Ghent160 enrolled1 locationNCT05562518
Recruiting
Not Applicable

Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy

Vaginal AtrophyVulvar Atrophy
Hillel Yaffe Medical Center20 enrolled1 locationNCT07024667
Recruiting
Not Applicable

Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Vulvo Vaginal AtrophyGenitourinary Syndrome of Menopause (GSM)Vaginal Atrophy in Breast Cancer Patients+4 more
Centre Hospitalier Universitaire Saint Pierre160 enrolled1 locationNCT06828640
Recruiting
Not Applicable

Pelvic Health Rehabilitation After Breast and Gynecologic Cancer

Breast Cancer FemaleGynecologic CancersIncontinence+4 more
Laval University20 enrolled2 locationsNCT06822582
Recruiting
Not Applicable

Treatment of Vaginal Atrophy With Low Intensity Nanosecond Neodymium Laser

Postmenopausal PeriodVaginal Atrophy
MeLSyTech, Ltd120 enrolled1 locationNCT05335317
Recruiting
Not Applicable

Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women With Vaginal Atrophy

Post Menopausal Vaginal Atrophy
Cairo University20 enrolled1 locationNCT06726746
Recruiting
Phase 2

Phyto-Soya Vaginal Gel Study

Menopausal Vaginal Atrophy
Arkopharma Australia60 enrolled1 locationACTRN12606000020583